{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:51:16Z","timestamp":1740135076061,"version":"3.37.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020618","name":"Universit\u00e4t Bayreuth","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020618","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer is the second most common cause of death in Germany, and treatment in certified cancer networks is recommended to ensure high-quality care. This study sought to (1) determine the percentage of all primary tumors that might potentially have been treated in certified cancer networks and (2) assess the development and current state of quality-assured cancer care for all cancer patients from a locally defined region in Upper Franconia, Germany.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study was a population-centered retrospective cohort analysis based on data from the Bavarian Cancer Registry (2017\u20132023). First, we determined all potentially available cancer network certifications and calculated the percentage of cancer care that could potentially have been conducted in certified cancer networks. Second, we considered the certification status of the involved healthcare providers and analyzed whether or not cancer care was actually carried out in certified cancer networks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 90.1% (62,119\/68,973) of all primary tumors, from a total of 63,372 patients, might potentially have been treated in certified cancer networks. The percentage of patients actually receiving care in certified cancer center networks was 40.7% for initial diagnosis, 59.0% for surgery, 53.2% for chemotherapy, and 50.7% for radiotherapy; the weighted mean was 50.3%. The results thus ranged between 46.9% (2023) and 52.8% (2022). The highest proportions of patients who received quality-assured treatment in certified cancer center networks were determined for breast cancer (79.5%), colon cancer (73.1%), and lymphoma (60.1%); in contrast, the lowest results were shown for lung cancer (2.7%), anal cancer (0.0%), and mesothelioma (0.0%). Female patients as well as younger patients were significantly more likely to receive care in certified care networks compared with their counterparts. In addition, we did not find a clear trend whether patients in different tumor stages were more or less likely to receive care in certified care networks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found meaningful differences in the proportion of patients who received quality-assured treatment in certified cancer center networks. Following this, patients should receive comprehensive information about receiving care in certified cancer center networks and consider longer travel distances, especially for those cancer types without locally available certified cancer networks.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-024-11972-3","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T10:35:26Z","timestamp":1732271726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality-assured treatment in certified cancer center networks in upper Franconia, Germany: a population-centered retrospective cohort analysis based on data of the Bavarian cancer registry"],"prefix":"10.1186","volume":"24","author":[{"given":"Martin","family":"Emmert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Gorodiscan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Thater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Buchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"M\u00fcller-Nordhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Rohrbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"11972_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. 2024. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/39-all-cancers-fact-sheet.pdf."},{"key":"11972_CR2","unstructured":"The German Federal Statistical Office. Health: Causes of death. 2024. https:\/\/www.destatis.de\/EN\/Themes\/Society-Environment\/Health\/Causes-Death\/_node.html."},{"key":"11972_CR3","unstructured":"The German Federal Statistical Office. Causes of death: Number of deaths has fallen by 1.6% in 2019. 2024. https:\/\/www.destatis.de\/EN\/Themes\/Society-Environment\/Health\/Causes-Death\/number-of-deaths.html."},{"key":"11972_CR4","unstructured":"The German Federal Statistical Office. World Cancer Day: record low of in-patient cancer treatments in 2021. 2023. https:\/\/www.destatis.de\/EN\/Press\/2023\/02\/PE23_N007_231.html."},{"key":"11972_CR5","unstructured":"Robert Koch-Institut (RKI). Krebs in Deutschland f\u00fcr 2019\/2020. 14th ed. Berlin; 2023."},{"key":"11972_CR6","unstructured":"The German Federal Statistical Office. Health: Cost of illness. 2024. https:\/\/www.destatis.de\/EN\/Themes\/Society-Environment\/Health\/Cost-Illness\/_node.html#267098."},{"volume-title":"Das Manual der Krebsregistrierung","year":"2019","key":"11972_CR7","unstructured":"Stegmaier C, Hentschel S, Hofst\u00e4dter F, Katalinic A, Tillack A, Klinkhammer-Schalke M, editors. Das Manual der Krebsregistrierung. M\u00fcnchen: W. Zuckerschwerdt; 2019."},{"key":"11972_CR8","unstructured":"Bundesministerium f\u00fcr Gesundheit. Ziele des Nationalen Krebsplans. 2022. https:\/\/www.bundesgesundheitsministerium.de\/themen\/praevention\/nationaler-krebsplan\/handlungsfelder\/ziele-des-nationalen-krebsplans.html. Accessed 19 Aug 2022."},{"key":"11972_CR9","unstructured":"German Cancer Society. Certification System. 2024. https:\/\/ecc-cert.org\/certification-system\/certification-system\/."},{"key":"11972_CR10","unstructured":"Krebsgesellschaft D, (DKG). Jahresbericht,. der zertifizierten Onkologischen Zentren. Berlin. 2021;31(12):2020."},{"key":"11972_CR11","unstructured":"Krebsgesellschaft D, (DKG). Jahresbericht,. der zertifizierten Onkologischen Zentren. Berlin. 2023;9(6):2023."},{"key":"11972_CR12","unstructured":"Stiftung Deutsche Krebshilfe. Netzwerk Onkologische Spitzenzentren: Das Netzwerk. 2023. https:\/\/www.ccc-netzwerk.de\/das-netzwerk\/mitglieder.html."},{"key":"11972_CR13","unstructured":"OnkoZert GmbH. OncoMap. 2022. https:\/\/www.oncomap.de\/centers?selectedOrgan=Brust. Accessed 11 Dec 2022."},{"key":"11972_CR14","unstructured":"Albert U, Fehm T, Fey H, Gebhardt M, H\u00fcbner J, Jurmeister P, et al. Patientinnenleitlinie: Brustkrebs im fr\u00fchen Stadium. Berlin; 2018."},{"key":"11972_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-0031-1280475","volume":"72","author":"C Kowalski","year":"2012","unstructured":"Kowalski C, Wesselmann S, Kreienberg R, Schulte H, Pfaff H. The patients\u2019 view on accredited breast cancer centers: strengths and potential for improvement. Geburtshilfe Frauenheilkd. 2012;72:137\u201343. https:\/\/doi.org\/10.1055\/s-0031-1280475.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"11972_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.breast.2014.11.014","volume":"24","author":"C Kowalski","year":"2015","unstructured":"Kowalski C, Ferencz J, Brucker S, Kreienberg R, Wesselmann S. Quality of care in breast cancer centers: results of benchmarking by the German Cancer Society and German Society for Breast Diseases. Breast. 2015;24:118\u201323. https:\/\/doi.org\/10.1016\/j.breast.2014.11.014.","journal-title":"Breast"},{"key":"11972_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000347098","volume":"8","author":"M Lux","year":"2013","unstructured":"Lux M, Hildebrandt T, Beyer-Finkler E, Bani M, Loehberg C, Jud S, et al. Relevance of health economics in breast cancer treatment - the view of certified breast centres and their patients. Breast Care (Basel). 2013;8:15\u201321. https:\/\/doi.org\/10.1159\/000347098.","journal-title":"Breast Care (Basel)"},{"key":"11972_CR18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00404-022-06666-2","volume":"307","author":"S-L Herbert","year":"2023","unstructured":"Herbert S-L, Hirzle P, Bartmann C, Schlai\u00df T, Kiesel M, Curtaz C, et al. Optimized process quality in certified breast centers through adherence to stringent diagnostic and therapeutic algorithms effects of structural as well as socio-demographic factors on start of therapy. Arch Gynecol Obstet. 2023;307:1097\u2013104. https:\/\/doi.org\/10.1007\/s00404-022-06666-2.","journal-title":"Arch Gynecol Obstet"},{"key":"11972_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000329601","volume":"34","author":"M Beckmann","year":"2011","unstructured":"Beckmann M, Brucker C, Hanf V, Rauh C, Bani M, Knob S, et al. Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients. Onkologie. 2011;34:362\u20137. https:\/\/doi.org\/10.1159\/000329601.","journal-title":"Onkologie"},{"key":"11972_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.breast.2012.01.009","volume":"21","author":"J Heil","year":"2012","unstructured":"Heil J, Gondos A, Rauch G, Marm\u00e9 F, Rom J, Golatta M, et al. Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. Breast. 2012;21:303\u20138. https:\/\/doi.org\/10.1016\/j.breast.2012.01.009.","journal-title":"Breast"},{"key":"11972_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-022-09731-w","volume":"22","author":"M Roessler","year":"2022","unstructured":"Roessler M, Schmitt J, Bobeth C, Gerken M, Kleihues-van Tol K, Reissfelder C, et al. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. BMC Cancer. 2022;22:1\u201310. https:\/\/doi.org\/10.1186\/s12885-022-09731-w.","journal-title":"BMC Cancer"},{"key":"11972_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12957-023-03262-9","volume":"22","author":"V Bierbaum","year":"2024","unstructured":"Bierbaum V, Bobeth C, Roessler M, Gerken M, Tol KK, Reissfelder C, et al. Treatment in certified cancer centers is related to better survival in patients with colon and rectal cancer: evidence from a large German cohort study. World J Surg Oncol. 2024;22:11. https:\/\/doi.org\/10.1186\/s12957-023-03262-9.","journal-title":"World J Surg Oncol"},{"key":"11972_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/iss-2021-0002","volume":"6","author":"M Richter","year":"2021","unstructured":"Richter M, Sonnow L, Mehdizadeh-Shrifi A, Richter A, Koch R, Zipprich A. German oncology certification system for colorectal cancer - relative survival rates of a single certified centre vs. national and international registry data. Innov Surg Sci. 2021;6:67\u201373. https:\/\/doi.org\/10.1515\/iss-2021-0002.","journal-title":"Innov Surg Sci"},{"key":"11972_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00345-020-03411-9","volume":"39","author":"MC Butea-Bocu","year":"2021","unstructured":"Butea-Bocu MC, M\u00fcller G, Pucheril D, Kr\u00f6ger E, Otto U. Is there a clinical benefit from prostate cancer center certification? An evaluation of functional and oncologic outcomes from 22,649 radical prostatectomy patients. World J Urol. 2021;39:5\u201310. https:\/\/doi.org\/10.1007\/s00345-020-03411-9.","journal-title":"World J Urol"},{"key":"11972_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12312-022-01158-5","volume":"38","author":"J R\u00fcckher","year":"2023","unstructured":"R\u00fcckher J, Utzig M, Stilgenbauer S, Loquai C, Gutzmer R, Wesselmann S. Was n\u00fctzt die Zertifizierung aus Sicht eines Zentrums? Forum. 2023;38:123\u20137. https:\/\/doi.org\/10.1007\/s12312-022-01158-5.","journal-title":"Forum"},{"key":"11972_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.ejso.2018.05.013","volume":"44","author":"F Trautmann","year":"2018","unstructured":"Trautmann F, Rei\u00dffelder C, Pecqueux M, Weitz J, Schmitt J. Evidence-based quality standards improve prognosis in colon cancer care. Eur J Surg Oncol. 2018;44:1324\u201330. https:\/\/doi.org\/10.1016\/j.ejso.2018.05.013.","journal-title":"Eur J Surg Oncol"},{"key":"11972_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12962-021-00273-9","volume":"19","author":"A Modabber","year":"2021","unstructured":"Modabber A, Schick D, Goloborodko E, Peters F, Heitzer M, Bock A, et al. Impact of quality certification of multidisciplinary head and neck tumor centers. Cost Eff Resour Alloc. 2021;19:20. https:\/\/doi.org\/10.1186\/s12962-021-00273-9.","journal-title":"Cost Eff Resour Alloc"},{"key":"11972_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00120-020-01321-7","volume":"60","author":"J Kranz","year":"2021","unstructured":"Kranz J, Grundmann RT, Steffens JA. Resultiert aus Struktur- und Prozessqualit\u00e4t zertifizierter Prostatakarzinomzentren eine bessere medizinische Versorgung? [Does structural and process quality of certified prostate cancer centers result in better medical care?]. Urologe A. 2021;60:59\u201366. https:\/\/doi.org\/10.1007\/s00120-020-01321-7.","journal-title":"Urologe A"},{"key":"11972_CR29","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/ijc.33728","volume":"149","author":"C-Y Cheng","year":"2021","unstructured":"Cheng C-Y, Datzmann T, Hernandez D, Schmitt J, Schlander M. Do certified cancer centers provide more cost-effective care? A health economic analysis of colon cancer care in Germany using administrative data. Int J Cancer. 2021;149:1744\u201354. https:\/\/doi.org\/10.1002\/ijc.33728.","journal-title":"Int J Cancer"},{"key":"11972_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/tbj.12444","volume":"21","author":"S Schrodi","year":"2015","unstructured":"Schrodi S, Tillack A, Niedostatek A, Werner C, Schubert-Fritschle G, Engel J. No survival benefit for patients with treatment in certified breast centers-A population-based evaluation of German cancer registry data. Breast J. 2015;21:490\u2013500. https:\/\/doi.org\/10.1111\/tbj.12444.","journal-title":"Breast J"},{"key":"11972_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10389-016-0728-5","volume":"24","author":"C Keinki","year":"2016","unstructured":"Keinki C, Ruetters D, Liebl P, Schroth S, Prott F-J, Micke O, Fuxius S. Is there evidence for better health care for cancer patients in certified centers? A systematic review J Public Health. 2016;24:351\u201361. https:\/\/doi.org\/10.1007\/s10389-016-0728-5.","journal-title":"A systematic review J Public Health"},{"key":"11972_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3238\/arztebl.m2023.0184","volume":"120","author":"A Stang","year":"2023","unstructured":"Stang A. Evaluability of the Effect of Oncology Center Certification. Dtsch Arztebl Int. 2023;120:645\u20136. https:\/\/doi.org\/10.3238\/arztebl.m2023.0184.","journal-title":"Dtsch Arztebl Int"},{"key":"11972_CR33","unstructured":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Medizinische Onkologie, editor. Deutschlandweite Prognose der bev\u00f6lkerungsbezogenen Morbidit\u00e4tserwartung f\u00fcr h\u00e4ufige Krebserkrankungen. 2nd ed. Berlin; 2020."},{"key":"11972_CR34","doi-asserted-by":"publisher","unstructured":"Friebel S, Thater A, V\u00f6lkel V, Klinkhammer-Schalke M, M\u00fcller-Nordhorn J, Emmert M. Qualit\u00e4tsgesicherte Behandlung in zertifizierten Versorgungsnetzwerken von Patientinnen mit Mammakarzinom in der Region Oberfranken: Eine Analyse auf Basis von Bayerischen Krebsregisterdaten. [Quality-assured treatment in certified breast cancer centre networks in Upper Franconia, Germany: An analysis based on data of the Bavarian Cancer Registry]. Gesundheitswesen 2024. https:\/\/doi.org\/10.1055\/a-2251-5564.","DOI":"10.1055\/a-2251-5564"},{"key":"11972_CR35","unstructured":"District Government of Upper Franconia. Information in English; 2024."},{"key":"11972_CR36","unstructured":"Bavarian Health and Food Safety Authority. Database Bavarian Cancer Registry; 2024."},{"key":"11972_CR37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1186\/s12913-017-2712-3","volume":"17","author":"W de Crupp\u00e9","year":"2017","unstructured":"de Crupp\u00e9 W, Geraedts M. Hospital choice in Germany from the patient\u2019s perspective: A cross-sectional study. BMC Health Serv Res. 2017;17:720. https:\/\/doi.org\/10.1186\/s12913-017-2712-3.","journal-title":"BMC Health Serv Res"},{"key":"11972_CR38","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(17)31280-1","volume":"390","author":"R Busse","year":"2017","unstructured":"Busse R, Bl\u00fcmel M, Knieps F, B\u00e4rnighausen T. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet. 2017;390:882\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(17)31280-1.","journal-title":"Lancet"},{"key":"11972_CR39","volume-title":"The German healthcare system: Strong","author":"The German Federal Ministry of Health","year":"2020","unstructured":"The German Federal Ministry of Health. The German healthcare system: Strong. Berlin: Reliable. Proven; 2020."},{"key":"11972_CR40","unstructured":"The German Federal Ministry of Health. Hospital Treatment. Berlin; 2022."},{"key":"11972_CR41","unstructured":"Bayerisches Staatsministerium f\u00fcr Gesundheit und Pflege. Krankenhausplan des Freistaates Bayern. 2022."},{"key":"11972_CR42","unstructured":"OnkoZert GmbH. Unternehmen: OnkoZert. 2023. Accessed 26 Apr 2023."},{"key":"11972_CR43","unstructured":"Landesamt B, f\u00fcr Statistik. Statistische Berichte, Einwohnerzahlen am 31. Dezember,. Gemeinden. Kreise und Regierungsbezirke in Bayern, Basis: Zensus. 2021;2011:2022."},{"key":"11972_CR44","unstructured":"Institute for Quality Assurance and Transparency in Health Care (IQTIG). Quality Report 2020. 2021. https:\/\/iqtig.org\/downloads\/berichte\/2019\/IQTIG_Qualitaetsreport-2020_2021-02-11.pdf."},{"key":"11972_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.25646\/11438","volume":"8","author":"C Spix","year":"2023","unstructured":"Spix C, Erdmann F, Grabow D, Ronckers C. Childhood and adolescent cancer in Germany - an overview. J Health Monit. 2023;8:79\u201394. https:\/\/doi.org\/10.25646\/11438.","journal-title":"J Health Monit"},{"key":"11972_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0169-2607(97)01809-9","volume":"53","author":"WL May","year":"1997","unstructured":"May WL, Johnson WD. A SAS macro for constructing simultaneous confidence intervals for multinomial proportions. Comput Methods Programs Biomed. 1997;53:153\u201362. https:\/\/doi.org\/10.1016\/s0169-2607(97)01809-9.","journal-title":"Comput Methods Programs Biomed"},{"key":"11972_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/00401706.1965.10490252","volume":"7","author":"LA Goodman","year":"1965","unstructured":"Goodman LA. On simultaneous confidence intervals for multinomial proportions. Technometrics. 1965;7:247\u201354. https:\/\/doi.org\/10.1080\/00401706.1965.10490252.","journal-title":"Technometrics"},{"key":"11972_CR48","first-page":"7","volume":"22","author":"O Schoffer","year":"2022","unstructured":"Schoffer O, Klinkhammer-Schalke M, Schmitt J. WiZen-Studie: \u00dcberlebensvorteile bei Behandlung in zertifizierten Krebszentren. GGW - Das Wissenschaftsforum in Gesundheit und Gesellschaft. 2022;22:7\u201315.","journal-title":"GGW - Das Wissenschaftsforum in Gesundheit und Gesellschaft"},{"key":"11972_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.breast.2018.04.002","volume":"40","author":"R Kreienberg","year":"2018","unstructured":"Kreienberg R, W\u00f6ckel A, Wischnewsky M. Highly significant improvement in guideline adherence, relapse-free and overall survival in breast cancer patients when treated at certified breast cancer centres: An evaluation of 8323 patients. Breast. 2018;40:54\u20139. https:\/\/doi.org\/10.1016\/j.breast.2018.04.002.","journal-title":"Breast"},{"key":"11972_CR50","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/1471-2407-14-757","volume":"14","author":"B Holleczek","year":"2014","unstructured":"Holleczek B, Brenner H. Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland. BMC Cancer. 2014;14:757. https:\/\/doi.org\/10.1186\/1471-2407-14-757.","journal-title":"BMC Cancer"},{"key":"11972_CR51","doi-asserted-by":"publisher","unstructured":"Bierbaum V, Schmitt J, Klinkhammer-Schalke M, Schoffer O. Potenzialabsch\u00e4tzung f\u00fcr die Konzentration der Versorgung von Krebspatient:innen in Kliniken mit DKG-Zertifizierung mittels \u00dcberlebenszeitanalyse. [Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival Analysis]. Gesundheitswesen. 2023;85:S197-S204. https:\/\/doi.org\/10.1055\/a-2132-6797.","DOI":"10.1055\/a-2132-6797"},{"key":"11972_CR52","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3238\/arztebl.m2023.0169","volume":"120","author":"J Schmitt","year":"2023","unstructured":"Schmitt J, Klinkhammer-Schalke M, Bierbaum V, Gerken M, Bobeth C, R\u00f6\u00dfler M, et al. Initial Cancer Treatment in Certified Versus Non-Certified Hospitals. Dtsch Arztebl Int. 2023;120:647\u201354. https:\/\/doi.org\/10.3238\/arztebl.m2023.0169.","journal-title":"Dtsch Arztebl Int"},{"key":"11972_CR53","unstructured":"H\u00f6lterhoff M, Klein R. Endbericht: Nutzen, Mehraufwand und Finanzierung von Onkologischen Spitzenzentren, Onkologischen Zentren und Organkrebszentren. Berlin\/D\u00fcsseldorf; 2017."},{"key":"11972_CR54","unstructured":"National Cancer Institute. Definition of carcinoma in situ - NCI Dictionary of Cancer Terms. 2024. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/carcinoma-in-situ. Accessed 22 May 2024."},{"key":"11972_CR55","unstructured":"German Cancer Society. Catalogue of Requirements: Lung Cancer Centres. Berlin; 2024."},{"key":"11972_CR56","unstructured":"Bavarian Health and Food Safety Authority. Cancer Registry: Database. 2024. https:\/\/www.lgl.bayern.de\/gesundheit\/krebsregister\/auswertung_forschung\/datenbank\/index.htm?Region=09400000&Diag_group%5B%5D=C33-C34&Method=CASESWITHDCO&Year_from=2015&Year_to=2019#result. Accessed 23 May 2024."},{"key":"11972_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00092-018-1832-3","volume":"22","author":"P Werthemann","year":"2018","unstructured":"Werthemann P, Wei\u00dfbach L. Zertifizierte Tumorzentren in Deutschland \u2014 auf Spurensuche. Uro-News. 2018;22:42\u20137. https:\/\/doi.org\/10.1007\/s00092-018-1832-3.","journal-title":"Uro-News"},{"key":"11972_CR58","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00761-021-01002-w","volume":"27","author":"J R\u00fcckher","year":"2021","unstructured":"R\u00fcckher J, Bokemeyer C, Fehm T, Graeven U, Wesselmann S. Das Zertifizierungssystem der Deutschen Krebsgesellschaft Onkologe. 2021;27:969\u201379. https:\/\/doi.org\/10.1007\/s00761-021-01002-w.","journal-title":"Das Zertifizierungssystem der Deutschen Krebsgesellschaft Onkologe"},{"key":"11972_CR59","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1055\/a-2055-9599","volume":"85","author":"E Berger","year":"2023","unstructured":"Berger E, Reichebner C, Eriksen A, Hildebrandt M, Kuklinski D, Busse R. Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: M\u00fcssen Patient*innen wirklich weitere Wege auf sich nehmen? [Specialised treatment of colorectal cancer in certified cancer centres: Do patients really have to travel further?]. Gesundheitswesen. 2023;85:657\u201366. https:\/\/doi.org\/10.1055\/a-2055-9599.","journal-title":"Gesundheitswesen"},{"key":"11972_CR60","doi-asserted-by":"publisher","unstructured":"Schirrmacher R, Rieger B, Justenhoven C. Behandlung in zertifizierten Lungenzentren (DKG) \u2013 Entscheidungsfaktoren von Patienten mit Lungenkrebs. [Treatment in Certified Centres (DKG): Decision Factors of Lung Cancer Patients]. Pneumologie. 2022;76:547\u201351. https:\/\/doi.org\/10.1055\/a-1877-4332.","DOI":"10.1055\/a-1877-4332"},{"key":"11972_CR61","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1245\/s10434-023-14709-4","volume":"31","author":"A Ahmed","year":"2024","unstructured":"Ahmed A, Whittington J, Shafaee Z. Impact of Commission on Cancer Accreditation on Cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis. Ann Surg Oncol. 2024;31:2286\u201394. https:\/\/doi.org\/10.1245\/s10434-023-14709-4.","journal-title":"Ann Surg Oncol"},{"key":"11972_CR62","unstructured":"American College of Surgeons. Commission on cancer: Standards and Resources; 2024."},{"key":"11972_CR63","unstructured":"Bayerisches Landesamt f\u00fcr Gesundheit und Lebensmittelsicherheit (LGL). Information des Bayerischen Krebsregisters (Newsletter M\u00e4rz 2023): \u00dcbersicht Vollz\u00e4hligkeit der Meldungen nach Regierungsbezirken in den Jahren 2017\u20132021. 2023. https:\/\/www.lgl.bayern.de\/downloads\/gesundheit\/krebsregister\/detailansicht.htm?ID=A%2Bs3RgSTi2RWSBLTQ%2FWu5g%3D%3D."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11972-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-11972-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11972-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T11:07:01Z","timestamp":1732273621000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-11972-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11972"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-11972-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was obtained from the University of Bayreuth Ethics Board (24\u2013049).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1453"}}